Category: Biotech

Cognetivity joins select group of UK scaleups deemed capable of achieving at least 50% annual growth VANCOUVER, BC, Feb. 11, 2021 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or...

Walker Announces Exploration Program Update From the Lapon Gold Project

by Abigale Lormen | Feb 10, 2021 | Biotech | 0

VANCOUVER, British Columbia, Feb. 10, 2021 (GLOBE NEWSWIRE) — Walker River Resources...

Cognetivity Neurosciences expands ongoing UK government-funded study to include Covid-safe remote cognitive assessment

by il27o | Jan 12, 2021 | Biotech | 0

Cognetivity’s iPad-based Integrated Cognitive Assessment (ICA) well suited to remote use as global demand for telehealth continues to surge VANCOUVER, BC, Jan. 12, 2021 /CNW/ – Cognetivity Neurosciences...

‘Blockbuster’ Migraine Therapy: Incentive for Lundbeck’s $2B Alder Acquisition

by Abigale Lormen | Sep 22, 2019 | Biotech | 0

Denmark’s international pharmaceutical company, Lundbeck has acquired Alder in a bid to...

Scientists Are One Step Closer to Treating Melanoma

by Abigale Lormen | Sep 7, 2019 | Biotech | 0

Last Sunday, researchers from the Massachusetts Institute of Technology presented their study...

NY Attorney General Probes Eli Lilly Over High Insulin Prices

by Abigale Lormen | Aug 3, 2019 | Biotech | 0

Eli Lilly has been served a subpoena from the Office of the Attorney General in New York because...

Gilead Beat Street Forecasts Due to Increasing Demand for HIV Drug

by Abigale Lormen | Aug 1, 2019 | Biotech | 0

Gilead Sciences Inc. (GILD.O) beat Wall Street forecasts for its profit and revenue for the second...

Cognetivity Neurosciences’ CMO to Present at Alzheimer’s Association International Conference (AAIC) 2019

by Editorial Staff | Jul 16, 2019 | Biotech, Markets, Tech | 0

AAIC is the Largest and Most Influential International Meeting Dedicated to Advancing Dementia Science Cognetivity’s Chief Medical Officer to Present Latest Company Research and Platform Capability Focused on Early...